Share markets in India are presently trading on a negative note.
The BSE Sensex is trading down by 390 points, down 0.8% at 48,644 levels.
Meanwhile, the NSE Nifty is trading down by 134 points.
UPL and Reliance are among the top gainers today. Tata Motors and Tata Steel are among the top losers today.
The BSE Mid Cap index is trading down by 1.9%.
The BSE Small Cap index is trading down by 1.8%.
--- Advertisement ---
The Smallcap Revival Summit
Join us on the evening of 28th January to learn,
• Why despite rallying over 100% since March-2020 lows... small-cap stocks are set for a massive rally over the coming months and years
• Details of our top 3 stocks to capture potentially huge gains from this upcoming small-cap rally
• And how to spot opportunities, even in the current market, with potential to generate 200%, 400%, and even 900% long-term gains
Plus there is a lot more that we are going to cover.
The summit is free to attend for Equitymaster readers.
But since there are limited seats, we would recommend you to register at the earliest.
Click here to register. It's free.
------------------------------
On the sectoral front, all sectors are trading in red with stocks from the metal sector, witnessing most of the selling pressure.
US stock futures are trading lower today, indicating a negative opening for Wall Street.
Nasdaq Futures are trading down by 20 points (down 0.2%) while Dow Futures are trading down by 31 points (down 0.1%).
The rupee is trading at 73.20 against the US$.
Gold prices are trading up 0.4% at Rs 48,880 per 10 grams.
BREAKING: Full Details of the #1 Investment of the Decade...
Gold prices in India extended their recent slide today when they slipped amid weak global cues. On MCX, gold futures fell 0.1% to over one month low of Rs 48,636 per 10 grams, extending their decline to the third day.
In the previous session, gold prices had declined Rs 500 per 10 grams while silver had slumped Rs 1,700 per kg.
To know more about gold, check out our article on how to invest in gold here: How to Invest in Gold?
Speaking of stock markets, Brijesh Bhatia, Research Analyst at Fast Profits Report, talks about why it might be the right time to take money off the table in pharma stocks, in his latest video for Fast Profits Daily.
Tune in here to find out more:
Moving on to stock specific news...
Among the buzzing stocks today is Wipro.
IT services major Wipro on January 16 said it has completed its Rs 95 billion share buyback programme. The buyback saw Azim Premji-affiliated entities tendering 229 million shares worth about Rs 91.5 billion during the process, a regulatory filing said.
--- Advertisement ---
Top 3 Stocks for 2020 and Beyond
We've uncovered 3 high-potential tech stocks after years of research.
These 3 cutting edge tech stocks could potentially create a wave of Indian millionaires.
First one is present in the sector which is expected to GROW over 300 times by 2030.
Second one is one of the leading players in Artificial Intelligence technology.
And the third one is involved in putting up a global safety net to save the world from cyber criminals.
These 3 tech stocks have the potential to offer life-changing gains in the long run.
Click here to get the details...
------------------------------
"(A total of) 237 million equity shares were bought back under the buyback at a price of Rs 400 per equity share. The total amount utilized in the buyback is Rs 95 billion," it added.
The tendering period for the buyback programme opened on December 29, 2020 and closed on January 11, 2021.
While Azim Premji Trust tendered 198.7 million shares, Mr Azim Hasham Premji Partner representing Hasham Traders tendered 10 million shares and Azim Premji Philanthropic Initiatives tendered 5.2 million shares.
Mr Azim Hasham Premji Partner representing Zash Traders and Mr Azim Hasham Premji Partner representing Prazim Traders tendered 750,000 shares each, it added.
Post completion of the buyback, the promoters hold 73% stake in the company, while the remaining 27% stake is held by foreign investors, financial institutions and others.
Note that earlier this month, Wipro's larger rival Tata Consultancy Services (TCS) also completed its Rs 160 billion buyback offer, under which over 53.3 million equity shares were bought back at a price of Rs 3,000 apiece.
At the time of writing, Wipro share price was trading up by 0.2% on the BSE.
Moving on to news from the pharma sector...
Diagnostic chain Metropolis Healthcare on January 17 said it will acquire Dr Ganesan's Hitech Diagnostic Centre in a cash and stock combination deal, to strengthen its leadership position in southern India.
The company's board has approved the acquisition partly by way of cash consideration of Rs 5.1 billion and partly by the issuance of up to 495,000 equity shares of a face value of Rs 2 each on a preferential basis, to the promoter group of Hitech. The cash consideration will be funded through internal accruals and debt of up to Rs 3 billion.
By the acquisition, Metropolis will get access to 31 laboratories, including three NABL- and ICMR-accredited laboratories and 68 collection centres of Hitech. The acquisition is expected to be completed within three months.
The acquisition will also allow Metropolis to increase its B2C business in focus cities of Chennai and Bengaluru. It will benefit through optimisation of operational costs in the areas of procurement, supply chain, administration and support resource, laboratory network and back-office infrastructure.
Hitech Diagnostic Centre's Promoter S P Ganesan said Metropolis is the right brand to carry forward the legacy of Hitech. "We shall ensure a smooth integration of Hitech's business with Metropolis to increase the value for the combined entity through cost synergies and create a much stronger consumer brand in South India.
Mr Ganesan will be part of the leadership team for the next few years to enable a smooth transition and integration with Metropolis.
How this pans out remains to be seen. Meanwhile, stay tuned for more updates from this space.
Speaking of the stock markets, here is an illustration of the four phases that a stock goes through during its life cycle. The cycle repeats itself after the stock goes through all these four stages.
This cycle defines everything in markets. If you can master this cycle, then nothing can stop you from making huge profits.
If you're interested to know how a stock's life cycle can offer you the opportunity to make money in every phase, you can read about it in one of the recent editions of Profit Hunter: One Cycle That Defines Everything in the Markets
And to know what's moving the Indian stock markets today, check out the most recent share market updates here.
For information on how to pick stocks that have the potential to deliver big returns, download our special report now!
Read the latest Market Commentary
What else is happening in the markets today? Dig in...
ONGC share price is trading down by 5% and its current market price is Rs 102. The BSE OIL & GAS is down by 2.0%. The top gainers in the BSE OIL & GAS Index are RELIANCE IND. (up 2.2%) and HPCL (up 0.5%). The top losers are ONGC (down 5.1%) and PETRONET LNG (down 6.9%).
Jan 18, 2021 03:34 PMNMDC share price is trading down by 5% and its current market price is Rs 122. The BSE 500 is down by 1.6%. The top gainers in the BSE 500 Index are UPL (up 6.1%) and TATA ELXSI (up 6.0%). The top losers are NMDC (down 5.1%) and L&T INFOTECH (down 6.5%).
Jan 18, 2021 03:32 PMHEG share price is trading down by 5% and its current market price is Rs 1,004. The BSE CAPITAL GOODS is down by 1.2%. The top gainers in the BSE CAPITAL GOODS Index are SIEMENS (up 0.7%) and SCHAEFFLER INDIA . The top losers are HEG (down 5.1%) and GRAPHITE INDIA (down 5.1%).
Jan 18, 2021 03:30 PMCOFORGE share price is trading down by 5% and its current market price is Rs 2,654. The BSE IT is down by 1.8%. The top gainers in the BSE IT Index are TATA ELXSI (up 5.6%) and FIRSTSOURCE SOLUTIONS (up 0.4%). The top losers are COFORGE (down 5.0%) and L&T INFOTECH (down 6.8%).
Jan 18, 2021 03:30 PMASTRAZENECA PHARMA share price is trading down by 5% and its current market price is Rs 4,200. The BSE HEALTHCARE is down by 2.5%. The top gainers in the BSE HEALTHCARE Index are GSK PHARMA (up 1.2%) and IPCA LABS (up 1.0%). The top losers are ASTRAZENECA PHARMA (down 5.3%) and WOCKHARDT (down 5.2%).
Jan 18, 2021 12:30 pmBSE Sensex is trading down by 390 points, while the NSE Nifty is trading down by 134 points.
View More Indian Share Market NewsMy new guide will show you the huge potential in future proof businesses.
Jan 8, 2021The smallcap rally has enough steam left in it. If you haven't joined yet, it is still not too late.
Jan 8, 2021The charts are telling the bulls to be cautious.
Jan 11, 2021Were you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...
More
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!